Harbor Capital Advisors, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $2.19 Billion
- Q1 2025
A detailed history of Harbor Capital Advisors, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 227 shares of AMPH stock, worth $5,543. This represents 0.0% of its overall portfolio holdings.
Number of Shares
227Holding current value
$5,543% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMPH
# of Institutions
274Shares Held
35MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$145 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$66.3 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$44.9 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$39 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$33.6 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.2B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...